Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
Official title: Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Run by University of Missouri-Columbia · NCT07083557 · Data updated 2026-11-12
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Missouri-Columbia Academic / other |
| Locations | 1 site (Columbia, Missouri) |
| Status | Recruiting |
| Started | January 1, 2027 |
| Main results expected | July 1, 2030 |
| Study ends | July 1, 2030 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT07083557 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–100 with a body mass index between 16.0 and 60 kg/m2 who are healthy or have relevant endocrine, cardiometabolic, or musculoskeletal conditions and who are not taking medications or supplements that interfere with the tested assays may qualify.
✕Probably not a fit
People who are pregnant, current smokers, prisoners, use interfering medications or supplements, have significant organ dysfunction (unless sought for validation), or cannot attend in-person procedures are unlikely to receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project compares results from current and new laboratory assays, intravenous catheter insertions, and equipment to determine reproducibility. Participants who are healthy or who have obesity, diabetes, atherosclerotic disease, heart failure, or MASH will undergo repeated measurements to see if the same results are achieved each time. Procedures may include blood draws, endothelial cell collection, standardized meals, and use of different devices or assays, with exclusions for medications, diets, or behaviors that could interfere. The work is conducted at the University of Missouri-Columbia to ensure accurate, repeatable testing for chronic disease and metabolism research.
Why it matters
Potential benefit: If successful, this work will increase confidence that lab tests and techniques produce accurate, repeatable results, improving the quality of research and supporting better clinical decisions.
How similar studies have gone: Similar validation and reproducibility efforts are common and have confirmed reliability for many established assays, although newer devices and methods often require fresh testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 and ≤100 years of age * body mass index ≥16.0 and ≤60 kg/m2 Exclusion Criteria: * \<18 and \>100 years of age * body mass index \<16.0 or \>60 kg/m2 * allergies, intolerances, or dietary restrictions to meal ingredients, vegans or vegetarians * use of medications or dietary supplements (e.g., anti-inflammatories, immune modulators, etc) that could interfere with the particular assay/techniques being evaluated * engaged in regular structured exercise \>150 min per week unless needed for validation of the assay/technique being evaluated * significant organ system dysfunction or diseases, except those that are sought for validation of the assay/technique being evaluated * alcohol use disorder as defined by the National Institute of Alcohol Abuse and Alcoholism or use of controlled substances unless alcohol use disorder is required for validation of the assay/technique being evaluated * pregnant women, persons who smoke, prisoners, and inability to grant voluntary informed consent.
Where it's running
-
University of Missouri-Columbia
Columbia, Missouri, United States Recruiting
Study contacts
- Principal investigator: Bettina Mittendorfer, PhD — University of Missouri-Columbia
- Study coordinator: Study coordinator
- Email: ahmc4@health.missouri.edu
- Phone: 573-884-6852
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Functional Muscle-Bone Incongruity Index: A look at muscle strength and bone health in adults
This observational study tests a composite FKUI score using handgrip strength and hip/spine bone density to see if it better reflects musculoskeletal health than each measure alone in adults undergoing routine DXA.
-
Assessing arterial stiffness and heart disease risk using a novel technology
This study is testing a new, no-touch technology to measure how stiff your arteries are and see if it can help figure out your risk for heart disease.
-
Understanding muscle loss in heart failure patients
This study looks at how factors like lifestyle and nutrition affect muscle loss in people with heart failure compared to healthy individuals.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Spatial multi-omics and AI-based early warning for pancreatic cancer cachexia
This study tests whether spatial multi-omics data can reveal how the tumor and body metabolism interact in pancreatic cancer cachexia and whether a multimodal AI model can predict cachexia early in adults with pancreatic ductal adenocarcinoma.
-
Sarcopenia in older adults with acute heart failure: using muscle ultrasound and biomarkers to predict outcomes
This study tests whether measuring muscle mass with ultrasound, along with muscle strength and biomarkers, can help predict outcomes for adults 80 and older hospitalized for acute heart failure with preserved ejection fraction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.